A Study to Evaluate Retisert in the Treatment of Patients With the "Wet" Form of Age-Related Macular Degeneration
NCT00032396 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL
Last updated 2006-05-29
Summary
A study evaluating Retisert in patients with age-related macular degeneration
Conditions
- Macular Degeneration
Interventions
- DRUG
-
Retisert Implant
Sponsors & Collaborators
-
Bausch & Lomb Incorporated
collaborator INDUSTRY -
Control Delivery Systems
lead INDUSTRY
Study Design
- Purpose
- TREATMENT
Eligibility
- Min Age
- 55 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2001-11-30
Countries
- United States
Study Locations
More Related Trials
-
Clinical Trial of Lutein for Patients With Retinitis Pigmentosa Receiving Vitamin A
NCT00346333 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Sun Filters on Age-related Macular Degeneration in People With Lens Implants
NCT00487838 ·Status: WITHDRAWN
-
Age-Related Eye Disease Study (AREDS) Follow-Up
NCT00594672 ·Status: ACTIVE_NOT_RECRUITING
-
Effects of Lutein in Retinitis Pigmentosa
NCT00029289 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Age-Related Macular Degeneration, Scotopic Dysfunction, and Driving Performance in a Simulator
NCT03166202 ·Status: COMPLETED
-
Study of Nutritional Supplementation in Patients With Unilateral Wet AMD
NCT04756310 ·Status: COMPLETED ·Phase: NA
-
Study of the Effects of Supplements on Eye Disease in Participants From the Age-Related Eye Disease Study
NCT01915238 ·Status: COMPLETED
-
Blood and Saliva Sample Collection for AREDS 2
NCT01553474 ·Status: COMPLETED
-
Oxidative Stress In Stargardt Disease, Age Related Macular Degeneration and Diabetic Retinopathy
NCT02875704 ·Status: TERMINATED
-
Age-Related Eye Disease Study 2 (AREDS2) 10-year Follow-On
NCT03367767 ·Status: COMPLETED
-
Dark Adaptation in Participants With Age-Related Macular Degeneration
NCT03225131 ·Status: ACTIVE_NOT_RECRUITING
-
Evaluation of a New Eye-specific Multivitamin Formula in Participants at Risk of Age-related Macular Degeneration (AMD)
NCT03946085 ·Status: COMPLETED ·Phase: NA
-
Augmented Macular Pigment-containing Nutraceutical and Central Visual Function
NCT04676126 ·Status: WITHDRAWN ·Phase: PHASE4
-
The Role of Macular Pigment in Patients With Age-related Macular Degeneration
NCT00494325 ·Status: COMPLETED
-
Lutein for Age-Related Macular Degeneration
NCT00006202 ·Status: COMPLETED ·Phase: PHASE2
-
Natural History, Pathogenesis, and Outcome of Ocular Disorders
NCT02821767 ·Status: RECRUITING
-
Functionally Validated Structural Endpoints for Early AMD
NCT04112667 ·Status: COMPLETED
-
Age-related Macular Degeneration (AMD) and Cardiovascular Disease
NCT04087356 ·Status: UNKNOWN
-
Evaluating Metabolic Changes Induced by PhotoBioModulation Through Spectrally Resolved Autofluorescence in Dry Age-Related Macular Degeneration Patients
NCT06582511 ·Status: ACTIVE_NOT_RECRUITING
-
Effect of Omega-3-fatty Acids on Blood Levels Omega-3 Fatty Acids in Patients With Age-related Macular Degeneration
NCT01653184 ·Status: COMPLETED ·Phase: NA
-
Age-Related Eye Disease Study (AREDS)
NCT00000145 ·Status: COMPLETED ·Phase: PHASE3
-
The Safety and Efficacy Study of Ethylenediaminetetraacetic Acid (EDTA) Ophthalmic Solution in Patients With Loss of Contrast Sensitivity Due to Age-Related, Low-Grade Nuclear Cataract
NCT06365762 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Intervention Trial in Early Age-related Macular Degeneration
NCT01694680 ·Status: COMPLETED ·Phase: NA
-
The Zeaxanthin and Visual Function Study
NCT00564902 ·Status: COMPLETED ·Phase: NA
-
Macular Pigment and Visual Performance in Glaucoma Patients
NCT03959592 ·Status: TERMINATED ·Phase: PHASE1/PHASE2